BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

USFDA Approves Treatment for Wider Range of Patients with Heart Failure

Jardiance was originally approved by the FDA in 2014 as a supplement to diet and exercise to improve glucose control in adults with type 2 diabetes. Jardia...

February 28, 2022 | News

GSK has launched the inaugural Shingles Awareness Week

GSK has launched the inaugural Shingles Awareness Week to educate the general public about shingles in collaboration with the International Federation on...

February 28, 2022 | News

Johns Hopkins to Offer Free Online Course for Consumer Health

Join the thousands of tobacco control professionals from across the globe who have expanded their knowledge on key issues by taking the free online course ...

February 22, 2022 | News

Analysis of DNA reveals weapons used by our immune cells to fight Tuberculosis

The team used high-throughput genomic technologies to learn how the DNA packaging inblood cells changes when a person has active TB, a bacterial disease th...

February 17, 2022 | News

Scientists breaking barriers to treating heart failure

Ceryx Medical Limited, together with scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, has developed tech...

February 16, 2022 | News

First Proton Therapy Treatment Delivered in Southeast Asia

The Varian ProBeam uses sophisticated imaging to see, adapt, and deliver treatment to the designated site, using a powerful particle accelerator called the...

February 09, 2022 | News

mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN

New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...

February 08, 2022 | News

NMN Supplement: A Promising Anti-Aging Product or Still An Encouraging Lab Experiment With Ongoing Clinical Trials?

However, the effect of time on the human biology is such that no matter how cautious we remain on the fronts of physical activity as well as diet, age alwa...

January 23, 2022 | News | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a pro...

January 12, 2022 | News

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...

January 07, 2022 | News

Aurobindo rolls out molnaflu, oral covid drug for adult patients In India

Molnupiravir was earlier approved under Emergency Use Authorisation from CDSCO, India. This is the first oral antiviral approved by India, the UK agency an...

January 06, 2022 | News

World's first automated 24/7 blood pressure monitor comes to the USA

Aktiia, the global leader in continuous blood pressure monitoring, today announced that it is bringing its 24/7 Blood Pressure Monitor to&nb...

January 04, 2022 | News

Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights

Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, a...

December 28, 2021 | News

Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China

The drug is an innovative traditional Chinese medicine (TCM) independently developed by Yiling Pharmaceutical based on clinical practices, applicable to mi...

December 24, 2021 | News

Stay Connected